
Jennifer E. Graser
Examiner (ID: 15, Phone: (571)272-0858 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1802, 1641, 1621 |
| Total Applications | 1979 |
| Issued Applications | 1306 |
| Pending Applications | 236 |
| Abandoned Applications | 472 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19043587
[patent_doc_number] => 11932671
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => Modified meningococcal fHbp polypeptides
[patent_app_type] => utility
[patent_app_number] => 17/245681
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 23491
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17245681
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/245681 | Modified meningococcal fHbp polypeptides | Apr 29, 2021 | Issued |
Array
(
[id] => 17185224
[patent_doc_number] => 20210332109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => ANTI-VARICELLA-ZOSTER VIRUS ANTIBODY, IMMUNOLOGICAL MEASUREMENT METHOD, AND IMMUNOLOGICAL MEASUREMENT DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/240580
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240580
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/240580 | Anti-varicella-zoster virus antibody, immunological measurement method, and immunological measurement device | Apr 25, 2021 | Issued |
Array
(
[id] => 18364366
[patent_doc_number] => 20230145957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => A VACCINE TO PROTECT AGAINST MYCOPLASMA HYOPNEUMONIAE
[patent_app_type] => utility
[patent_app_number] => 17/917987
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917987
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/917987 | Vaccine to protect against mycoplasma hyopneumoniae | Apr 18, 2021 | Issued |
Array
(
[id] => 20451868
[patent_doc_number] => 12514912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Compositions comprising three OspA fusion proteins for medical use
[patent_app_type] => utility
[patent_app_number] => 17/917624
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 37
[patent_no_of_words] => 14601
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917624
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/917624 | Compositions comprising three OspA fusion proteins for medical use | Apr 8, 2021 | Issued |
Array
(
[id] => 17170385
[patent_doc_number] => 20210324055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => Methods, Devices, Kits and Compositions for Detecting Tapeworm
[patent_app_type] => utility
[patent_app_number] => 17/224544
[patent_app_country] => US
[patent_app_date] => 2021-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26480
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17224544
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/224544 | Methods, Devices, Kits and Compositions for Detecting Tapeworm | Apr 6, 2021 | Abandoned |
Array
(
[id] => 20372663
[patent_doc_number] => 12480089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Antiviral treatment comprising Blis containing probiotic products
[patent_app_type] => utility
[patent_app_number] => 17/916421
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10721
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916421
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916421 | Antiviral treatment comprising Blis containing probiotic products | Mar 30, 2021 | Issued |
Array
(
[id] => 17156469
[patent_doc_number] => 20210317520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => MUTANT PORES
[patent_app_type] => utility
[patent_app_number] => 17/215506
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17215506
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/215506 | Mutant pores | Mar 28, 2021 | Issued |
Array
(
[id] => 18496138
[patent_doc_number] => 20230218684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => ENGINEERED BACTERIA FOR USE IN VACCINE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/995069
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995069
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995069 | ENGINEERED BACTERIA FOR USE IN VACCINE COMPOSITIONS | Mar 28, 2021 | Pending |
Array
(
[id] => 17141736
[patent_doc_number] => 20210309748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => ANTI HLA-G SPECIFIC ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 17/212165
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17351
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17212165
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/212165 | ANTI HLA-G SPECIFIC ANTIBODIES | Mar 24, 2021 | Abandoned |
Array
(
[id] => 18436423
[patent_doc_number] => 20230183717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => POLYPEPTIDES WITH PEROXIDASE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/914215
[patent_app_country] => US
[patent_app_date] => 2021-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914215
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/914215 | Polypeptides with peroxidase activity | Mar 23, 2021 | Issued |
Array
(
[id] => 18461665
[patent_doc_number] => 11685949
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-27
[patent_title] => Mutant pore
[patent_app_type] => utility
[patent_app_number] => 17/194472
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 64
[patent_no_of_words] => 58917
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194472
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194472 | Mutant pore | Mar 7, 2021 | Issued |
Array
(
[id] => 18461665
[patent_doc_number] => 11685949
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-27
[patent_title] => Mutant pore
[patent_app_type] => utility
[patent_app_number] => 17/194472
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 64
[patent_no_of_words] => 58917
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194472
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194472 | Mutant pore | Mar 7, 2021 | Issued |
Array
(
[id] => 17050725
[patent_doc_number] => 20210260159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => CD40L-Fc FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/194658
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194658
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194658 | CD40L-Fc FUSION POLYPEPTIDES AND METHODS OF USE THEREOF | Mar 7, 2021 | Abandoned |
Array
(
[id] => 16946741
[patent_doc_number] => 20210205432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => PROTEINS AND IMMUNIZING COMPOSITIONS CONTAINING PASTEURELLA PROTEINS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/191913
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191913
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/191913 | Proteins and immunizing compositions containing | Mar 3, 2021 | Issued |
Array
(
[id] => 18531101
[patent_doc_number] => 20230236172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => T Cells That Respond To Patient Neoepitopes
[patent_app_type] => utility
[patent_app_number] => 17/906782
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906782
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906782 | T Cells That Respond To Patient Neoepitopes | Mar 3, 2021 | Abandoned |
Array
(
[id] => 18307699
[patent_doc_number] => 20230111599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => VACCINES COMPRISING GLYCOENGINEERED BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/908829
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908829
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908829 | VACCINES COMPRISING GLYCOENGINEERED BACTERIA | Mar 2, 2021 | Pending |
Array
(
[id] => 17080642
[patent_doc_number] => 20210275648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => SOUTHERN CATTLE TICK VACCINE PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/190235
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12672
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17190235
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/190235 | Southern cattle tick vaccine product | Mar 1, 2021 | Issued |
Array
(
[id] => 18349479
[patent_doc_number] => 20230137590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => COMPOSITIONS AND METHODS FOR PRODUCING DISEASE SUPPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/908514
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908514
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908514 | COMPOSITIONS AND METHODS FOR PRODUCING DISEASE SUPPRESSION | Mar 1, 2021 | Pending |
Array
(
[id] => 18449647
[patent_doc_number] => 20230190923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => COMPOSITIONS COMPRISING LTB AND PATHOGENIC ANTIGENS, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/802465
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17802465
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/802465 | COMPOSITIONS COMPRISING LTB AND PATHOGENIC ANTIGENS, AND USE THEREOF | Feb 24, 2021 | Abandoned |
Array
(
[id] => 19140512
[patent_doc_number] => 20240139302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => PROPIONIBACTERIUM ACNES PROPHYLACTIC AND THERAPEUTIC IMMUNE TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/801099
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 136575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801099
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/801099 | PROPIONIBACTERIUM ACNES PROPHYLACTIC AND THERAPEUTIC IMMUNE TREATMENT | Feb 21, 2021 | Pending |